The data, which was analyzed by healthcare research firm 3 Axis Advisors, indicated prices are expected to increase about 5% in January, according to Antonio Ciaccia, president of the firm, told the news outlet. He said a 5% jump in price each year is typical to keep pace with inflation.
The drugmakers attribute the bump to inflation and ongoing supply chain issues, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.